Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies—Perspectives from the American Society of Onco-Nephrology (ASON),Clinical Journal of the American Society of Nephrology

当前位置： X-MOL 学术 › Clin. J. Am. Soc. Nephrol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies—Perspectives from the American Society of Onco-Nephrology (ASON)
Clinical Journal of the American Society of Nephrology ( IF 8.5 ) Pub Date : 2024-06-07 , DOI: 10.2215/cjn.0000000000000509
Abhijat Kitchlu ₁ , Verônica T. Costa E Silva _{2,

3} , Shuchi Anand ₄ , Jaya Kala ₅ , Ala Abudayyeh ₆ , Lesley A. Inker ₇ , Mitchell H. Rosner ₈ , Sabine Karam ₉ , Prakash Gudsoorkar ₁₀ , Shruti Gupta ₁₁ , Sheldon Chen ₆ , Nattawat Klomjit ₉ , Nelson Leung ₁₂ , Tomaz Milanez ₁₃ , Shveta S. Motwani ₁₄ , Sheikh B. Khalid ₁₁ , Vinay Srinivasan ₁₅ , Rimda Wanchoo ₁₆ , Jan H. Beumer ₁₇ , Geoffrey Liu ₁₈ , Nizar M. Tannir ₁₉ , Ani Orchanian-Cheff ₂₀ , Yimin Geng ₆ , Sandra M. Herrmann ₁₂

Affiliation

Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, ON, Canada
Serviço de Nefrologia, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
Laboratório de Investigação Médica (LIM) 16, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, BR
Department of Medicine (Nephrology), Stanford University, Stanford, CA, USA
Division of Renal Diseases and Hypertension, University of Texas Health Science Center at Houston-McGovern Medical School, Houston, TX, USA
Section of Nephrology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
Division of Nephrology, Tufts Medical Center, Boston, USA
Division of Nephrology, University of Virginia Health, Charlottesville, VA, USA
Division of Nephrology and Hypertension, University of Minnesota, Minneapolis, Minnesota, USA
Division of Nephrology, Kidney C.A.R.E. Program, University of Cincinnati, Cincinnati, OH, USA
Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Lahey Hospital and Medical Center, Burlington, MA, USA
Division of Nephrology, Cooper University Hospital and Cooper Medical School of Rowan University, Camden, NJ, USA
Division of Kidney Diseases and Hypertension, Glomerular Center at Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, NY, USA
Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA
Princess Margaret Cancer Centre and University Health Network, University of Toronto, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Library and Information Services, University Health Network, Toronto, Ontario, Canada